IR
Disc Medicine
IRON·NASDAQCambridge MAFounded 2017110 employees
Mid CapbiotechPublicHematologyRare Disease
Platform: Iron Biology
Market Cap
$3B
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (IRON)
Loading IRON stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zenorelsin | IRO-4973 | NDA/BLA | 2 | JAK2 | LNPsoriasis | ||
| IRO-8712 | IRO-8712 | Preclinical | 1 | JAK2 | RA | ||
| Tirasacituzumab | IRO-4544 | NDA/BLA | 2 | PI3Kα | PAHRA |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)